Kilmarnock mum’s fight to get her ‘miracle’ son medical cannabis



Kilmarnock mum’s fight to get her ‘miracle’ son medical cannabis


Yvonne Chafey wants her son Logan to go on a trial to help with his rare condition.





Logan Chafey is one of a kind.

The three-year-old Kilmarnock toddler is the only person in Europe with chromosome 7p duplication.

The genetic condition is so rare and unknown to scientists that there is no official name for it yet.

The side-effects of the chromosome abnormality include epilepsy and autism; the latter of which means that little Logan can suffer multiple seizures every day.


Now his mum, Yvonne, says that his current medication is having a debilitating effect on her son – leaving him feeling sick and irritable.

The 40-year-old has pleaded with medical chiefs to let Logan trial medical cannabis. But Yvonne has claimed NHS Ayrshire and Arran bosses said that Logan doesn’t meet the criteria.

She believes that CBD oil could potentially rid her son of his ailments and give him a better quality of life.

But so far, the Caprington mum’s prayers have gone unanswered.


“I think it’s terrible we’re being denied this opportunity, I really do,” Yvonne told the Kilmarnock Standard. “It’s so frustrating.

“I’ve been researching this for about a year and a lot of people have stated that the cannabis oil seems to help massively. Not just for epilepsy but for autism as well. That alone speaks for itself.”

Yvonne, who works as a golf starter at Caprington Golf Course, has admitted that she’s lucky her son is here today after a tough introduction to the world in June 2015.


“I’ve had problems with Logan since I was pregnant with him,”Yvonne added.

“He wasn’t supposed to survive. He was on ventilators when he was born. I had premature ruptures of the membrane at 19 weeks so Logan shouldn’t be here really.


He’s a wee bit of a miracle. He was born up at the Southern General and I just kept raising concerns about him since we brought him home.

“He was too quiet. Babies should cry and he didn’t cry a lot. We went from there and had genetic testing and it came back that he had a rare genetic condition and then we got the autism diagnosis and then we got the diagnosis for epilepsy.”


For Yvonne and husband Scott, 45, this was not the first time they had encountered issues with genetic conditions.

As well as Logan, the pair have one daughter, Jenna, 12, and Yvonne gave birth to twins Scott and Mya eight years ago. But a genetic disorder meant that Mya tragically passed away three hours after being born.


Logan’s epilepsy medication keeps him awake and we have to give him melatonin. That has to be up in order for him to be able to sleep,” Yvonne said.

“He’s had a spinal injury because they increased the epilepsy medication and he was running into walls and doors.

“Logan has been in the hospital with a head injury.


He’s burst his nose, he’s burst his mouth and his head.

“We’ve had paramedics in the house and they weren’t able to move Logan for half an hour because he was still in seizure.

“It’s absolutely horrendous to see him go through this when there is something out there that could possibly help him and could potentially eradicate his seizures and we’re not allowed it.”


And Yvonne said it would mean the world to her to get a medical cannabis trial.

She said: “We don’t know where we’re going with this but it’s difficult.

“You just get on with it. There’s no point dwelling on it but I’m really just trying to turn a negative into a positive and do the best I can for him really.


“It would mean the world to us.

“I’d actually be relieved if they let him go on the trial and hope that he wouldn’t have side-effects the way his medication is with him now.”

Roisin Kavanagh, NHS Ayrshire and Arran interim director of pharmacy said: “NHS Ayrshire and Arran cannot comment on the treatment of individual patients.

“To support safe and effective prescribing of cannabis-based medicinal products guidance for clinicians is being produced nationally.



“As advised by the Scottish Government, NHS Ayrshire and Arran will consider the use of cannabis-based medicinal products where there is clear published evidence of benefit; or where there is a clinical need that cannot be met by a licensed medicine and all other established treatment options have been exhausted.

“Trials of medicines are coordinated by the National Institute of Health Research and they are currently seeking proposals to evaluate the safety and clinical effectiveness of cannabis-based medicinal products.”


Logan’s fight taken to Prime Minister
Earlier this month, Logan’s plight was brought before Prime Minister Theresa May by Kilmarnock and Loudoun MP Alan Brown when he pressed on the issue of medicinal cannabis at Prime Minister’s questions.

The PM said: “Obviously the honourable gentleman has raised a distressing case about his constituent. We have taken the steps to ensure that medicinal cannabis is available.

“The decision on that availability is one that is taken by clinicians and I think that is absolutely right that that’s what should be done.”



Mr Brown said: “At the moment the current rules and regulations are just far too restrictive.

“It seems to be a way of the UK Government appearing they are amenable to patients getting access to medical cannabis products, but in reality they are not.


“As Logan is a unique case, in Europe under the current rules he will never get access to medical cannabis as there is no ‘proven benefit’ it works for someone with his diagnosis.

“This shows the absurdness of the process – this is why I raised the matter at Prime Minister’s questions recently.


“I also believe the biggest blocker is the Prime Minister herself, as she has a very old-fashioned world view in these matters.

“In her response she said it was up to clinicians to decide but the current rules put the decisions in the hands of very few people.

“I have submitted a number of written parliamentary questions on the subject and will be writing directly to the PM as a follow up to her misleading response.”







Residents fed up with drugs in their community urged to ‘dob in a dealer’



Residents fed up with drugs in their community urged to ‘dob in a dealer’


Two busts in Plympton and Honicknowle this week after residents become sick and tired of suspected drug dealers and users


A young person pictured smoking cannabis


Suspected drug dealers in Plymouth have been warned that police are on their heels because their neighbours are fed up with them.

Officers have told Plymouth Live that in recent weeks they had received a number of reports from residents in the Chaddlewood area of Plympton, complaining about scores of visitors to an address during both the day and night. In addition, residents became aware of the pungent odour of cannabis and noted that a number of the regular visitors were “youngsters”.


As a result of information gathered by the police neighbourhood beat manager officers from the Plymouth North and Plympton Proactive Unit attended an address in Acres Close at around 3pm on Wednesday and carried out a search.

A quantity of cannabis was found, along with grinders and other assorted drug paraphernalia. Officers also seized a mobile phone and a man was arrested on suspicion of possession with intent to supply class B drugs.


A spokesman for the Unit said social services were contacted in relation to children residing at the property and safeguarding assessments which needed to be carried out. In addition, information was also passed by the police to the housing association who maintain the building regarding the tenant.

The man was later interviewed by police at Charles Cross police station and released under investigation.


The arrest follows another incident on March 13 which saw officers from the same unit carry out a search off a property in Butt Park Road, Honcknowle.

The spokesman said: “Again we were given information from the community about issues surround an address.




“A search of the property revealed a small cannabis grow of four or five plants, around two to three feet high and a quantity of cannabis contained in a pillow-case sized bag which we believe was brought to the property rather than grown there.”

It is understood two people were arrested in connection with the discovery of the drugs.


The unit spokesman added: “Both these incidents came about because residents were increasingly concerned about people attending these properties at all hours to purchase illegal items, and they were particularly concerned about quite young people turning up.



The public’s help is vital in tackling the issue of drug supply and we rely on them to pass us the intelligence.

“We will continue to get these results if we get the intel and we would urge them to call us on 101 or pass information anonymously to Crimestoppers on 0800 555111.”

Anyone with information about the Acres Close matter is urged to contact police quoting crime reference number CR/024883/19











UK: Cannabis oil treated my epilepsy and I went from Universal Credit to a job: why is it so hard to get?

“My life isn’t ruled by my epilepsy any more. I don’t feel like someone who has severe epilepsy any more.

Read more at:

Luke O’Donnell worries that cannabis oil is already in short supply for those who need to use it for medicinal reasons



Luke O’Donnell, who has severe epilepsy, says cannabis oil has changed his life (Photo: Luke O’Donnell)


This time last year, Luke O’Donnell, 25, was suffering from such severe epilepsy that his day-to-day was hampered by debilitating seizures. His seizures were so frequent and unpredictable that he became reclusive. He couldn’t work, so he had to claim Universal Credit. But seizures meant he missed Jobcentre appointments, which landed him with sanctions. In the last six months, his life has turned around. He barely gets a seizure now and when he does, they last for only a couple of minutes.



Luke, from Lincoln, is now working full-time as a telephone adviser for a telecoms company. To him, this transformation is down to one thing: cannabis oil. However, due to issues with the licensing of the drug, Luke has not been given a prescription. He has managed to source some on his own and takes it, he says, with the blessing of his neurologist. Although Luke trusts his source, those who are forced to turn to the black market cannot be as confident.


“My neurologist said you need to be careful of the source,” he tells i. “You need to know what fertilisers they are using because some of them can be very dangerous. It’s not a regulated product, you don’t know how pure it is or if someone has adulterated it.


“I trust my source, I don’t know whether other people can trust theirs. That makes me a bit uncomfortable, especially if they’re giving it to their children.


” Given his transformation and reports of how medicinal cannabis has helped others, Luke is baffled as to why the drug is not more readily available for those who really need it.


“Yes it can be prescribed but there’s nothing to prescribe. Ultimately I’d like for there to be some concrete guidelines about the kinds of oils that can be prescribed and where they come from,” he adds.


“At the minute it’s a black market. You get a bottle with a green liquid and that could be anything.


 Tastes ‘foul’

Luke starting taking cannabis oil about six months ago, dropping a small does under his tongue every day. He went weeks without seizures and when he did have one, it was relatively minor and he only zoned out of consciousness for a few minutes. This marked a huge shift from the “status epilepticus” he used to experience.


“I would be in and out of repeated convulsive seizures. Sometimes I might have a convulsive seizure that lasts for five to 10 minutes. Other times it would last until a paramedic shoved a cannula in me and injected me with Diazepam,” he says.


The nature of his condition made him feel like he could not work. He even had a seizure during a job interview.


On another occasion, Luke wet himself following a “big seizure” on a bus. He says he lost the confidence to go out alone after this.


Luke was given medication, a type of benzodiazepine – a psychoactive drug – but it came with side effects.


“I was given it as a rescue medication but then I was told to take it day-to-day because my epilepsy had gotten that serious. It did let me function but at the same time it’s a psychoactive [substance], so it made me very slow and very apathetic.”


More control over life

Luke gets his cannabis oil from Portugal


With the cannabis oil, the seizures are minimal and there are no side effects. Luke says he has more freedom and control over his life and he does not live in fear of being struck with a seizure.


“I feel a lot more confident about going out. There’s not that worry at the back of my mind: ‘Oh Christ, am I going to have a seizure on a train?’


He says he no longer worries about the impact his seizures will have at him on work.

“Now my absences are really insignificant. I did actually have a seizure [at work] on Saturday. It was very small, two minutes, towards the end of my shift. My boss put me on some admin work and when I went home, I felt fine. Beforehand I would have felt really out of it for about a week. It really messes you up when you have a big seizure.


“My life isn’t ruled by my epilepsy any more. I don’t feel like someone who has severe epilepsy any more.


Cannabis oil prescriptions Medicinal cannabis can be used to manage the symptoms of a range of conditions including epilepsy. Since autumn 2018, specialist doctors have been able to legally prescribe it on the NHS after cannabis was reclassified to allow some products to be prescribed for medicinal use in some situations. The decision to relax the rules comes after high profile cases in which families campaigned to get cannabis oil for their children with epilepsy. But as a result of restrictive guidance and the fact medicinal cannabis remains unlicensed, doctors have only given out a small number handful of prescriptions. Those who have been given a prescription struggle to get their hands on the drug. Families have lobbied Parliament for more access but England’s Chief Medical Officer has called for randomised control trials to get cannabis drugs licensed for use.



From Universal Credit to full-time work

“I’ve gone from someone on Universal Credit who is not even able to attend their appointments and has to battle ridiculous sanctions to working full-time and earning a salary in around six months. It’s astonishing. “Twice a day, I take a drop of this foul tasting oil and I can go to work. I can go out. I can go to Manchester to see my brother, go on a night out. I can go down to London to see my university friends. I’ve got so much more freedom. “If [cannabis oil] stops me having seizures for long enough I will be able to drive. I should be able to go swimming without having to pre-warn the lifeguard: ‘I’ve got epilepsy, you might have to keen an eye on me.’ It’s quite embarrassing having to do that.” Luke is excited about his future and wants the same for others who have epilepsy. He is calling on health bodies to put a framework in place which encourages doctors to give out more prescriptions and ensures regulated supplies of medicinal cannabis are available.



The Department of Health and Social Care said: “The Government has changed the law and specialist doctors can now prescribe cannabis based medical products where there is clinical evidence of benefit.


“To support these doctors we have asked NICE [National Institute for Health and Care Excellence] to develop new clinical guidelines and Health Education England to provide additional training, while encouraging more national research to further improve the evidence base.”


NHS England said: “The decision to prescribe medicinal cannabis is a clinical decision for specialist hospital doctors, made with patients and their families, to determine the most appropriate medication or course of treatment for an individual patient.”




The Royal Pharmaceutical Society (RPS) is advising patients to speak to their consultant about medicinal cannabis “rather than purchase an oil independently from an unregulated provider”.


“Recent changes to regulations in the UK mean there is a framework in place for specialist clinicians to treat patients with cannabis-based medicines if they think it appropriate. However, as there are not yet any licensed products available in the UK, which assure quality and efficacy, this is not straightforward and interim guidance from some royal colleges has advised caution,” said Aileen Bryson, deputy director at RPS in Scotland.


“We await NICE guidance in the Autumn to provide further direction,” she added.

Read more at:


The man who co-invented Viagra is now developing cannabis products so women can have better sex



The man who co-invented Viagra is now developing cannabis products so women can have better sex


The marijuana-based vaginal gel is not a “medicine” but more like a “sexual enhancer”





Men have a wide variety of resources to help them with sexual dysfunction. The sexual needs of women are largely overlooked. Dr. Harin Padma-Nathan, co-inventor of Niagra, is hoping to change this narrative by developing a cannabis-based gel that will help women have better sex.


Dr. Padma-Nathan was the lead principal investigator for Viagra and Cialis, two prominent FDA-approved sexual dysfunction drugs. Now, he has teamed up with Manna Molecular, a cannabis biotech firm, to oversee development of cannabinoid-based sexual health products. The company is known to make cannabis transdermal patches—transdermal patches are medicated adhesive placed on the skin to deliver a specific dose.


A 2018 study points out that the “treatment of male sexual dysfunction has developed considerably since the release of sildenafil (Viagra) as a treatment for erectile dysfunction in 1998. Unfortunately, despite robust clinical and academic interest in male sexual dysfunction, women with sexual complaints have been largely overlooked. There have been limited treatment options, few Canadian role models who specialize in female sexual medicine, and little academic activity in the area of female sexual function.”

Interestingly, the idea for the product—Nial DeMena, CEO of Manna Molecular, admits—came through the company’s female colleagues. “DeMena became interested in exploring cannabis-based sexual health products for women when the company’s female customers reported that wearing their cannabis patches on their pelvis improved their sexual experiences. That feedback inspired DeMena to approach Padma-Nathan about the possibility of using cannabis to enhance sex for women. Padma-Nathan told him there’s pretty good evidence that it could,” Civilized reports.

“The evidence is that in lower doses, cannabis enhances sexual function, and at extremely high doses, it may have a detrimental effect,” Dr. Padma-Nathan told Civilized.

Cannabis can’t completely treat sexual dysfunction like Viagra does. So the company plans to market this cannabis-based vaginal gel as a sexual enhancement product as opposed to medicine. “This is not a treatment for a severe medical issue. We want to be conservative in what we promise,” Dr. Padma-Nathan told Civilized.



Now here’s why Canadians should be excited: In Feb. 2019, Aphria signed a worldwide license agreement with Manna Molecular that allows the Canadian pot company to produce and sells patches containing cannabis oils for its established suite of medical and adult-use brands.

Could pot be women, what viagra is for men? Once approved, is it headed towards the Canadian markets? Only time will tell.


Want to keep up to date on what’s happening in the world of cannabis?  Subscribe to the Cannabis Post newsletter for weekly insights into the industry, what insiders will be talking about and content from across the Postmedia Network.




SNP MP fights for medical cannabis access: ‘These medicines are legal, but no-one can get them’



SNP MP fights for medical cannabis access: ‘These medicines are legal, but no-one can get them’




Ronnie Cowan was among 80 MPs to deliver a petition of 570,000 signatures to 10 Downing Street calling for the guidance of medical cannabis to reviewed

SNP MP Ronnie Cowan has condemned the difficulty facing the families of severely epileptic children seeking access to medical cannabis, and has called on the UK Government to intervene.

Cowan, the vice-chair of the all-party parliamentary group on medical cannabis under prescription and a long-time advocate a drug law reform, was among 80 MPs to meet with a delegation of sixteen such families last week, before marching in silence up Whitehall to deliver a petition with over 570,000 signatures to 10 Downing Street, calling on the UK Government to take action and review current guidance on medical cannabis.



Access to medical cannabis was legalised after a series of high-profile cases in the summer of 2018, including that of six-year-old Alfie Dingley. However, at the present time it is believed there have been no new NHS prescriptions for the type of medical cannabis now used by Dingley, and the families of other children in similar situations have expressed their frustration at the lack of access to such medicines.


Cowan said: “The law was changed for good reason and the public are rightly outraged that the new policy has been introduced in a way that means these medicines are legal, but no-one can get them. 

“The stories of the families are heart-breaking. All have been refused access. Some have been told to go abroad! Some have even proved that medical cannabis works for their child but have still been blocked. 

“I’ve offered them my continuing support and previously met with the Minster for Public Health, Steve Brine MP, to press the UK Government to intervene and break this deadlock. I was pleased to be one of over 100 co-signatories on the letter to Matt Hancock urging him to intervene.”


Labour MP Tonia Antoniazzi, another of the MPs who delivered the petition, also commented: “We want to raise the profile of the fact that the law has changed but the situation hasn’t changed because children are not getting prescriptions that they need to treat their epilepsy.

“There is no guidance for doctors and someone somewhere is stopping them from prescribing medical cannabis.”

Peter Carroll, from the campaign group End Our Pain added: “Last year’s law change only came about because MPs felt moved to support the high profile campaigning families last summer. 

“We have ended up in the bizarre and seemingly cruel situation in which the red tape surrounding access to medical cannabis is so tight that if the children at the centre of last year’s campaigns were put through it even they wouldn’t get a prescription. The NHS and the medical professional bodies have effectively blocked the entire policy. 



“We accept that there should be a degree of caution in adopting new medicines, but the current situation is totally unacceptable”.

Responding to the delivery of the petition, a UK Government spokesperson said: “To support these doctors we have asked NICE [National Institute for Health and Care Excellence] to develop new clinical guidelines and Health Education England to provide additional training, while encouraging more national research to further improve the evidence base.”

The Scottish Government has repeatedly called on the UK Government to devolve control over cannabis to the Holyrood, most recently in June of 2018 following the announcement of a UK Government review into medicines derived from the plant.

Speaking to CommonSpace at the time, a Scottish Government spokesperson said: “We believe responsibility in this area should be devolved so that future decisions on these issues would be for the Scottish Parliament to consider.”



The Rise of The Cannabis Clinic Model In Europe



The Rise of The Cannabis Clinic Model In Europe


The first of a chain of private cannabis clinics has just opened in the UK, but what does this mean for publicly insured patients if not the rest of Europe?


The opening of the UK’s first cannabis clinic is certainly cause for cheer. The effort, backed by a growing UK powerhouse that includes European Cannabis Holdings, has just opened its first private cannabis clinic in the UK, with two more on the way, including one in London by the end of the year.

The clinic will see patients who can afford to pay, in other words those who are privately insured and not covered by the NHS. The clinics will also serve those with chronic illnesses including chronic pain and epilepsy.

This development will also undoubtedly begin to increase the number of actual legal British cannabis patients, which is significant in and of itself. That count now, close to five months after cannabis became technically available via Schedule II prescription last year, is a shocking four patients. This is not a typo.

Presumably, this means that patients who enter the market this way will also be able to access newly imported Dutch cannabis which has just started to enter the country in bulk. Not to mention be able to find pharmacies who stock the drug.


For the backers of ECH (which include SOL Global), these are strategic moves indeed, which also bode well for those who can afford access.

But does this herald a new shift in the way that cannabis will be prescribed for the mainstream in the UK if not across Europe? That is not so clear.

The History of Cannabis Clinics… In Israel and Beyond
From the medical side of the world, it has been cannabis specialty pain clinics that have moved the conversation forward and served patients in places like Israel. In the latter part of the last decade, Israel slowly began to liberalize access not via dispensaries, as in the American model, but rather via specialty pain clinics paid for by the government. It was only when patient attendance at such prescription and dispensation points became flooded by applicants that the government, just a few short years ago, began to allow regular doctors to prescribe the drug and regular pharmacies to carry it.



here are currently various initiatives sprinkled around Europe- mostly in the form of collectives of doctors who try to help get their patients cannabinoid treatments. See, for example, Kalapa Clinic in Spain. Or the “self help” group of patients in Germany loosely associated with Dr. Grotenhermann (one of the country’s best-known cannabinoid doctors).

Yet in Germany, the first country in Europe to liberalize medical use, there are as yet no cannabis clinics of either the private or public kind (although there have also been several unsuccessful attempts to do just this since 2017 in cities like Berlin and Munich). Part of the reason for the failure of the model in Germany at least is due to the fact that while specialty doctors are needed to help guide patients through the complicated approvals process, the payment for the same from the insurance companies (even private insurers) is so low it is not yet economically feasible to set up a clinic based on this model.

That said, it is clearly an idea that has occurred to more than a few entities. In Germany, however, land of (at least) 40,000 patients, this model has yet to take off. What does this say about a British market where reform has just come, and only four patients? Even as early as spring 2017, when the German government changed the law mandating insurance coverage, there were 800 German patients in the system.


Why The UK Is Likely To Be Different



Cannabis patients may actually be some of the best situated patients to ride out the Brexit crisis that will hit all drugs. Why? From the start, the strange classification of the drug is requiring bespoke solutions for niche patients. While it may not be fair, this in turn will at least start to create a core group of medical users.

Creating at least that first critical mass is also unbelievably important for greater access and reform, if not speeding it on its way. And the backers of the new clinics are well aware that impetus on this front will not come from the much-beleaguered NHS but rather private initiatives like the ones now being launched in the UK.




Brixworth mother marches on No 10 as part of campaign to give son access to medical cannabis



Brixworth mother marches on No 10 as part of campaign to give son access to medical cannabis



Julie Young (right) wants to know why her son Lloyd (centre) cannot access a medical cannabis prescription.



A Brixworth mother joined a march on Downing Street on Tuesday to hand over a 570,000 strong petition to loosen the restrictions on medical cannabis. Julie Young was thinking of her epileptic son Lloyd every step of the way from Parliament to No 10 as part of the End Our Pain march.



She joined the families of 16 other children who have been denied access to the treatment in a bid to lobby parliament on the NHS’ tight restrictions to THC-active cannabis oil – which was legalised in November but so far has only been prescribed to one child in four months. The march even saw Secretary of State for Health Matt Hancock personally address the families about why their children had not been able to access the drug. Julie said: “It was a brilliant day. We have raised the profile on how to get the blockers to this treatment unblocked. “It won’t happen immediately. It could take another six months or longer. “But we had a great turn out and handed in hundreds of thousands of signatures to No 10.” For Julie, she wanted to know why her 16-year-old son Lloyd is one of many children turned down from even trying the treatment when it could be the answer they’re looking for. Lloyd is at risk of a life-threatening seizure every hour of the day and must be watched constantly. He takes up to 30 pills a day to manage his epilepsy – and because was born non-verbal and autistic, he cannot even tell his parents and doctors what he’s going through. Julie said: “He’s still a child. To have a child on so many drugs is as damaging as having a hundred seizures a day. “We’ve got to try. Cannabis oil might not even work for Lloyd. But when will it become an option?” Cannabis oil available under a NHS prescription has THC as an active ingredient. It is the same substance found in high doses in marijuana and is not available commercially. But although cannabis oil was legalised in November, it is still unlicensed, meaning it is only available on the NHS is their needs ‘can’t be met’ by all other licensed medicines.





Woman, 57, SMILES in her mugshot after she’s arrested for ‘handing out marijuana-infused cookies and gummy candies’ at a Wisconsin St. Patrick’s Day parade



Woman, 57, SMILES in her mugshot after she’s arrested for ‘handing out marijuana-infused cookies and gummy candies’ at a Wisconsin St. Patrick’s Day parade


daily mail


A woman testing her luck selling weed cookies and candies at a Wisconsin St. Patrick’s Day parade has been arrested. 

Cathleen Krause, 57, was allegedly handing out weed infused cookies and treats during the holiday parade in Wescott on Sunday and appeared ‘visibly intoxicated’ herself. 

In Wisconsin, only medical marijuana is legal and is extremely limited. Recreational use of weed is illegal and possession of cannabis can land violators six months in jail or a fine of up to $1,000. 


Cathleen Krause, 57, smiled ear-to-ear in her mugshot after she was arrested on Sunday for allegedly handing out marijuana infused cookies and candies at the St. Patrick's Day parade in Wescott, Wisconsin


Police were called to the scene after an unnamed person reported seeing Krause selling the goods. 

When officers approached her she was found intoxicated with a gallon-sized bag of cookie crumbs and also had gummy candy on her.  

All of her treats tested positive for marijuana. 


Unfazed, Krause smiled ear-to-ear in her mugshot. 

She was charged with two felony counts of delivering THC and possession of THC as well as three misdemeanor charges of possession of a controlled substance. 

She is not allowed to leave the state of Wisconsin without permission and was ordered to maintain ‘absolute sobriety’. 

She appeared in court in a video conference on March 18 to be charged. 

Her next court appearance is scheduled for April 1 for an ‘adjourned initial appearance’.




Top Hitter


She’s my new best friend


Mrs. White, Exeter, United States





Roofer who got high on ‘exotic’ strains of drug



Roofer who got high on ‘exotic’ strains of drug




A ROOFER who got high on ‘exotic’ strains of marijuana has admitted being concerned in the supply of the drug.

David Shambach sourced forms of cannabis with such names as ‘Dreamweaver’, ‘Banana Cream’ and ‘Cherry Gorilla’ at illegal trade fairs, Greenock Sheriff Court was told.

Lawyer David Tod said Shambach, 27, ‘developed an interest in cannabis’ and began self-medicating following an injury more than three years ago which resulted in him being hospitalised.

Mr Tod told the court: “The names on the labels caused some mirth with officers at his [police] interview.”



The solicitor added that Shambach’s drug supply offence was akin to a collector of ‘exotic miniatures’ of alcohol who ‘lets his friends drink them’.

However, Mr Tod’s plea in mitigation on behalf of his client still resulted in a fine of £1,500 — with Sheriff Daniel Kelly describing the offence as a ‘serious’ matter.

Shambach, of Roxburgh Avenue in Greenock, was told that the fine would have been £2,000 had he not pleaded guilty.

Prosecutor Lindy Scaife told the court how police turned up at Shambach’s home with a search warrant on the morning of August 31 last year.

The fiscal depute added: “The first item found was a bag of herbal cannabis labelled ‘Black Russian’.

“The total weight of all of the cannabis found was 100 grams, with a value of around £850.”


The court heard that there was also tablet and chocolate products labelled ‘Baked Bakers’ which also contained cannabis.

Lawyer Mr Tod said: “As a result of his wrongful interest he went to things called cannabis fairs and bought different strains, not to grow but to smoke and try out.

“He accepts that given his interest he had pals who found out about it and they would ask to try the different strains he’d sourced at these fairs.

“In essence, samples were given and it was not enough to be commercial [supply].”

Mr Tod told the court: “Mr Shambach is a self-employed roofer.





“The products were commercially labelled and it was not him who put the labels on them.”


Chief Minister signals support for medicinal cannabis cultivation



Chief Minister signals support for medicinal cannabis cultivation


THE Chief Minister has come out in support of developing a medicinal cannabis industry – providing it can be taxed and does not damage the Island’s reputation.




Earlier this month the JEP revealed that the Economic Development Department is planning to issue licences to grow the crop in the hope of raising hundreds of millions in revenue from exports and re-invigorating the agricultural industry.

It is understood that a number of potential growers are interested and several planning applications have been made to convert old agricultural buildings and glasshouses into hydroponic cultivation sites.

Speaking at the Institute of Directors’ mid-year review yesterday, Chief Minister John Le Fondré indicated for the first time support for the project, subject to two caveats.

‘I was briefed on it before Christmas. My general view is that provided it does not damage the Island’s reputation, and I understand that to be the case, that there could be a significant economic and tax benefit to it,’ he said.


‘One of my crucial questions is that we need to make sure that we can tax revenue on it as well.

‘If the numbers are what they are talking about then this is of significant interest.’

‘So, my view is the two criteria are (a) that we have the revenue mechanism in place and (b) reputation-wise that it does not damage us.’

Senator Le Fondré added that he feels it could be a ‘very good opportunity’ for the Island but would need to be acted upon quickly so that Jersey gets ahead of the global market.

When announcing his plans to pursue the medicinal cannabis market, Economic Development Minister Lyndon Farnham said that he Island could be an attractive growing location due to reputation for tight regulation and security.


He also outlined that as well as boosting agriculture, the move could generate jobs in research and intellectual property.





Your message has been successfully sent.
Oops! Something went wrong.

Get in touch

If you wish to enquire about anything, or just say hi, please fill in the form opposite, or email us on:

Copyright 2020